share_log
Benzinga ·  Aug 21 08:10
Monopar Therapeutics Shares Are Trading Higher After the Company Announced It Received the Australia Human Research Ethics Committee Clearance to Proceed With Its Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment